The Net Margin of Sangamo Therapeutics Inc (SGMO) is -169.45%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -169.45% |
2023-12-31 | -146.30% |
2022-12-31 | -172.78% |
2021-12-31 | -161.07% |
2020-12-31 | -102.37% |
2019-12-31 | -92.97% |
2018-12-31 | -80.83% |
2017-12-31 | -149.18% |
2016-12-31 | -369.59% |
2015-12-31 | -103.04% |